{"id":46092,"date":"2022-07-12T19:01:46","date_gmt":"2022-07-12T17:01:46","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/results-from-a-double-blind-randomized-controlled-trial-of-scallop-derived-plasmalogens-published-in-frontiers-in-cell-and-developmental-biology\/"},"modified":"2022-07-12T19:01:46","modified_gmt":"2022-07-12T17:01:46","slug":"results-from-a-double-blind-randomized-controlled-trial-of-scallop-derived-plasmalogens-published-in-frontiers-in-cell-and-developmental-biology","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/results-from-a-double-blind-randomized-controlled-trial-of-scallop-derived-plasmalogens-published-in-frontiers-in-cell-and-developmental-biology\/","title":{"rendered":"Results from a Double-blind Randomized Controlled Trial of Scallop-derived Plasmalogens Published in Frontiers in Cell and Developmental Biology"},"content":{"rendered":"<div>\n<p>FUKUOKA, Japan&#8211;(BUSINESS WIRE)&#8211;The Japanese Plasmalogen Society (Office: Higashi-ku, Fukuoka, Japan; President: Yutaka Oomura) announced the research results that scallop-derived plasmalogens administered to college athletes improved sleep disorders, negative mood and mental concentration.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220707005871\/en\/1507926\/5\/org_logo20220708111932phpbNFuVf.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220707005871\/en\/1507926\/21\/org_logo20220708111932phpbNFuVf.jpg\"><\/a><\/p>\n<p>\nPlasmalogens, a class of phospholipids, serve vital roles in the body, including antioxidant action, ion transport, cholesterol efflux and membrane fusion. Plasmalogens are known to protect the brain against oxidative damage, and to activate brain function. Notably, scallop-derived plasmalogens, compared to sea squirt- and chicken-derived plasmalogens, abundantly contain DHA-rich plasmalogens, which have been found to be more effective for cognitive function than other types of plasmalogens in the previous studies.\n<\/p>\n<p>\nThe research team led by Dr. Takehiko Fujino, Professor emeritus of Kyushu University, revealed significant improvements in the plasmalogen-treated group compared to the placebo group by conducting a RCT.\n<\/p>\n<p>\nKey findings are as follows:\n<\/p>\n<ol class=\"bwlistdecimal\">\n<li>\nSleep problems were significantly alleviated.\n<\/li>\n<li>\n\u201cAnger-Hostility\u201d and \u201cFatigue-Inertia\u201d of the mood scale were significantly improved.\n<\/li>\n<li>\nMental concentration was boosted.\n<\/li>\n<\/ol>\n<p>\nSleep disorders assessed by the Athens Insomnia Scale were significantly improved in the plasmalogen-treated group while no such improvement was found in the placebo group. There were significant improvements in Anger-Hostility and Fatigue-Inertia of Profile of Mood States 2 (POMS2) in the plasmalogen-treated group, but not in the placebo group. Study participants with stronger negative moods showed more marked improvement. The plasmalogen-treated group showed a continuous improvement in the scores of the Uchida-Kraepelin test during the tests, while the placebo group showed the slowing down in the scores at min 5.\n<\/p>\n<p>\nMental concentration is a crucial factor that often determines the success or failure of study, work and sports. Poor concentration is one of the symptoms of mental illness such as depression. The research results have shown that orally administered scallop-derived plasmalogens markedly improve a stronger negative mood and then enhance mental concentration in athletes. This suggests that scallop-derived plasmalogens would be useful for anyone who hopes to be free from a negative mood and to be lively.\n<\/p>\n<p>\nThese findings were published in Frontiers in Cell and Developmental Biology, a leading, open-access, peer-reviewed scientific journal (Impact Factor 6.684).\n<\/p>\n<p>\n<b>Article Title: <\/b>Orally Administered Plasmalogens Alleviate Negative Mood States and Enhance Mental Concentration: A Randomized, Double-Blind, Placebo-Controlled Trial.<br \/>\n<br \/><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.frontiersin.org%2Farticles%2F10.3389%2Ffcell.2022.894734%2Ffull&amp;esheet=52774646&amp;newsitemid=20220707005871&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.frontiersin.org%2Farticles%2F10.3389%2Ffcell.2022.894734%2Ffull&amp;index=1&amp;md5=20cc77411187274073d704c4f010c4e6\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2022.894734\/full<\/a>\n<\/p>\n<p>\nFor more details, please visit at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fpls.jp%2Fwp-content%2Fuploads%2FPressRelease202207.pdf&amp;esheet=52774646&amp;newsitemid=20220707005871&amp;lan=en-US&amp;anchor=https%3A%2F%2Fpls.jp%2Fwp-content%2Fuploads%2FPressRelease202207.pdf&amp;index=2&amp;md5=a1e1b3f54755de9a41381ede9f76a44e\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/pls.jp\/wp-content\/uploads\/PressRelease202207.pdf<\/a>.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nNaoe Hiraishi<br \/>\n<br \/>The Japanese Plasmalogen Society<br \/>\n<br \/><a target=\"_blank\" href=\"mailto:i&#110;&#102;&#111;&#64;&#112;&#108;&#115;&#46;&#106;&#112;\" rel=\"nofollow noopener\" shape=\"rect\">&#x69;&#x6e;&#x66;&#x6f;&#x40;&#x70;&#x6c;&#x73;&#x2e;&#x6a;&#x70;<\/a><br \/>+81 92 273 2411\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>FUKUOKA, Japan&#8211;(BUSINESS WIRE)&#8211;The Japanese Plasmalogen Society (Office: Higashi-ku, Fukuoka, Japan; President: Yutaka Oomura) announced the research results that scallop-derived plasmalogens administered to college athletes improved sleep disorders, negative mood and mental concentration. Plasmalogens, a class of phospholipids, serve vital roles in the body, including antioxidant action, ion transport, cholesterol efflux and membrane fusion. Plasmalogens are &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/results-from-a-double-blind-randomized-controlled-trial-of-scallop-derived-plasmalogens-published-in-frontiers-in-cell-and-developmental-biology\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46092","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Results from a Double-blind Randomized Controlled Trial of Scallop-derived Plasmalogens Published in Frontiers in Cell and Developmental Biology - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/results-from-a-double-blind-randomized-controlled-trial-of-scallop-derived-plasmalogens-published-in-frontiers-in-cell-and-developmental-biology\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Results from a Double-blind Randomized Controlled Trial of Scallop-derived Plasmalogens Published in Frontiers in Cell and Developmental Biology - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"FUKUOKA, Japan&#8211;(BUSINESS WIRE)&#8211;The Japanese Plasmalogen Society (Office: Higashi-ku, Fukuoka, Japan; President: Yutaka Oomura) announced the research results that scallop-derived plasmalogens administered to college athletes improved sleep disorders, negative mood and mental concentration. Plasmalogens, a class of phospholipids, serve vital roles in the body, including antioxidant action, ion transport, cholesterol efflux and membrane fusion. Plasmalogens are ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/results-from-a-double-blind-randomized-controlled-trial-of-scallop-derived-plasmalogens-published-in-frontiers-in-cell-and-developmental-biology\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-12T17:01:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220707005871\/en\/1507926\/21\/org_logo20220708111932phpbNFuVf.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/results-from-a-double-blind-randomized-controlled-trial-of-scallop-derived-plasmalogens-published-in-frontiers-in-cell-and-developmental-biology\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/results-from-a-double-blind-randomized-controlled-trial-of-scallop-derived-plasmalogens-published-in-frontiers-in-cell-and-developmental-biology\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Results from a Double-blind Randomized Controlled Trial of Scallop-derived Plasmalogens Published in Frontiers in Cell and Developmental Biology\",\"datePublished\":\"2022-07-12T17:01:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/results-from-a-double-blind-randomized-controlled-trial-of-scallop-derived-plasmalogens-published-in-frontiers-in-cell-and-developmental-biology\\\/\"},\"wordCount\":408,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/results-from-a-double-blind-randomized-controlled-trial-of-scallop-derived-plasmalogens-published-in-frontiers-in-cell-and-developmental-biology\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220707005871\\\/en\\\/1507926\\\/21\\\/org_logo20220708111932phpbNFuVf.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/results-from-a-double-blind-randomized-controlled-trial-of-scallop-derived-plasmalogens-published-in-frontiers-in-cell-and-developmental-biology\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/results-from-a-double-blind-randomized-controlled-trial-of-scallop-derived-plasmalogens-published-in-frontiers-in-cell-and-developmental-biology\\\/\",\"name\":\"Results from a Double-blind Randomized Controlled Trial of Scallop-derived Plasmalogens Published in Frontiers in Cell and Developmental Biology - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/results-from-a-double-blind-randomized-controlled-trial-of-scallop-derived-plasmalogens-published-in-frontiers-in-cell-and-developmental-biology\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/results-from-a-double-blind-randomized-controlled-trial-of-scallop-derived-plasmalogens-published-in-frontiers-in-cell-and-developmental-biology\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220707005871\\\/en\\\/1507926\\\/21\\\/org_logo20220708111932phpbNFuVf.jpg\",\"datePublished\":\"2022-07-12T17:01:46+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/results-from-a-double-blind-randomized-controlled-trial-of-scallop-derived-plasmalogens-published-in-frontiers-in-cell-and-developmental-biology\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/results-from-a-double-blind-randomized-controlled-trial-of-scallop-derived-plasmalogens-published-in-frontiers-in-cell-and-developmental-biology\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/results-from-a-double-blind-randomized-controlled-trial-of-scallop-derived-plasmalogens-published-in-frontiers-in-cell-and-developmental-biology\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220707005871\\\/en\\\/1507926\\\/21\\\/org_logo20220708111932phpbNFuVf.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220707005871\\\/en\\\/1507926\\\/21\\\/org_logo20220708111932phpbNFuVf.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/results-from-a-double-blind-randomized-controlled-trial-of-scallop-derived-plasmalogens-published-in-frontiers-in-cell-and-developmental-biology\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Results from a Double-blind Randomized Controlled Trial of Scallop-derived Plasmalogens Published in Frontiers in Cell and Developmental Biology\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Results from a Double-blind Randomized Controlled Trial of Scallop-derived Plasmalogens Published in Frontiers in Cell and Developmental Biology - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/results-from-a-double-blind-randomized-controlled-trial-of-scallop-derived-plasmalogens-published-in-frontiers-in-cell-and-developmental-biology\/","og_locale":"en_US","og_type":"article","og_title":"Results from a Double-blind Randomized Controlled Trial of Scallop-derived Plasmalogens Published in Frontiers in Cell and Developmental Biology - Pharma Trend","og_description":"FUKUOKA, Japan&#8211;(BUSINESS WIRE)&#8211;The Japanese Plasmalogen Society (Office: Higashi-ku, Fukuoka, Japan; President: Yutaka Oomura) announced the research results that scallop-derived plasmalogens administered to college athletes improved sleep disorders, negative mood and mental concentration. Plasmalogens, a class of phospholipids, serve vital roles in the body, including antioxidant action, ion transport, cholesterol efflux and membrane fusion. Plasmalogens are ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/results-from-a-double-blind-randomized-controlled-trial-of-scallop-derived-plasmalogens-published-in-frontiers-in-cell-and-developmental-biology\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-12T17:01:46+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220707005871\/en\/1507926\/21\/org_logo20220708111932phpbNFuVf.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/results-from-a-double-blind-randomized-controlled-trial-of-scallop-derived-plasmalogens-published-in-frontiers-in-cell-and-developmental-biology\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/results-from-a-double-blind-randomized-controlled-trial-of-scallop-derived-plasmalogens-published-in-frontiers-in-cell-and-developmental-biology\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Results from a Double-blind Randomized Controlled Trial of Scallop-derived Plasmalogens Published in Frontiers in Cell and Developmental Biology","datePublished":"2022-07-12T17:01:46+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/results-from-a-double-blind-randomized-controlled-trial-of-scallop-derived-plasmalogens-published-in-frontiers-in-cell-and-developmental-biology\/"},"wordCount":408,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/results-from-a-double-blind-randomized-controlled-trial-of-scallop-derived-plasmalogens-published-in-frontiers-in-cell-and-developmental-biology\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220707005871\/en\/1507926\/21\/org_logo20220708111932phpbNFuVf.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/results-from-a-double-blind-randomized-controlled-trial-of-scallop-derived-plasmalogens-published-in-frontiers-in-cell-and-developmental-biology\/","url":"https:\/\/pharma-trend.com\/en\/results-from-a-double-blind-randomized-controlled-trial-of-scallop-derived-plasmalogens-published-in-frontiers-in-cell-and-developmental-biology\/","name":"Results from a Double-blind Randomized Controlled Trial of Scallop-derived Plasmalogens Published in Frontiers in Cell and Developmental Biology - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/results-from-a-double-blind-randomized-controlled-trial-of-scallop-derived-plasmalogens-published-in-frontiers-in-cell-and-developmental-biology\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/results-from-a-double-blind-randomized-controlled-trial-of-scallop-derived-plasmalogens-published-in-frontiers-in-cell-and-developmental-biology\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220707005871\/en\/1507926\/21\/org_logo20220708111932phpbNFuVf.jpg","datePublished":"2022-07-12T17:01:46+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/results-from-a-double-blind-randomized-controlled-trial-of-scallop-derived-plasmalogens-published-in-frontiers-in-cell-and-developmental-biology\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/results-from-a-double-blind-randomized-controlled-trial-of-scallop-derived-plasmalogens-published-in-frontiers-in-cell-and-developmental-biology\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/results-from-a-double-blind-randomized-controlled-trial-of-scallop-derived-plasmalogens-published-in-frontiers-in-cell-and-developmental-biology\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220707005871\/en\/1507926\/21\/org_logo20220708111932phpbNFuVf.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220707005871\/en\/1507926\/21\/org_logo20220708111932phpbNFuVf.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/results-from-a-double-blind-randomized-controlled-trial-of-scallop-derived-plasmalogens-published-in-frontiers-in-cell-and-developmental-biology\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Results from a Double-blind Randomized Controlled Trial of Scallop-derived Plasmalogens Published in Frontiers in Cell and Developmental Biology"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46092","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46092"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46092\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46092"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46092"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46092"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}